Home / Pharmaceuticals / Influenza Therapeutics Market By Therapy Type (Vaccines, Drugs) - Growth, Share, Opportunities & Competitive Analysis, 2015 - 2025

Influenza Therapeutics Market By Therapy Type (Vaccines, Drugs) - Growth, Share, Opportunities & Competitive Analysis, 2015 - 2025

Published: Jul 2017 | Report Code: 58535-07-17

Global influenza therapeutics market is anticipated to grow significantly during forecast period due to growing prevalence of influenza, increasing demand for treatment medication, government initiatives in awareness and treatment would drive the growth of influenza therapeutics market globally.

The report titled “Influenza Therapeutics Market - Growth, Future Prospects and Competitive Analysis, 2017–2025” offers strategic insights into the overall influenza therapeutics market along with the market size and estimates for the duration 2015 to 2025. The research study covers in-depth analysis of market segments based on technology and different geographical regions.

Geographically, the global influenza therapeutics market is studied for the following regional markets:   

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • Rest of Asia Pacific
  • Latin America
  • Middle East and Africa

Market size and forecast for these regional and country level markets are presented in this study for the period 2015-2025. Market growth rates for the forecast period 2017-2025 are also included in this report, considering 2016 as the base year.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges and opportunities assists the readers for understanding the ongoing trends in the global influenza therapeutics market. Tools such as market positioning of key players and attractive investment proposition provide the readers with insights on the competitive scenario of the global influenza therapeutics market. This report concludes with company profiles section that highlights major information about the key players engaged in global Influenza therapeutics market. In-depth competitive environment analysis and historical years (2015) market size data are also provided in the report.      

Thus, the research study provides a holistic view of the global influenza therapeutics market, offering market size and estimates for the period from 2015 to 2025, keeping in mind the above-mentioned factors.

Influenza Therapeutics Market

Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions

Chapter 2 Executive Summary
2.1 Global Influenza Therapeutics Market Snapshot
2.2 Global Influenza Therapeutics Market, by Therapy Type, 2016 (US$ Mn)
2.3 Global Influenza Therapeutics Market Share, by Geography, 2016 (Value %)

Chapter 3 Influenza Therapeutics Market Analysis
3.1 Global Influenza Therapeutics Market Overview
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.1.1 Increase in prevalence of Influenza
3.2.2 Challenges
3.2.2.1 Poor Patient Compliance in some countries
3.2.3 Opportunities
3.3 Pipeline Analysis
3.4 Attractive Investment Proposition
3.5 Competitive Landscape of Key Players in Influenza Market

Chapter 4 Global Influenza Therapeutics Market, by Therapy Type
4.1 Overview
4.3 Vaccines
4.4 Drugs

Chapter 5 Global Influenza Therapeutics Market, By Geography
5.1 Preface
5.2 North America (U.S. & Canada)
5.3 Europe (U.K., Germany & Rest of Europe)
5.4 Asia Pacific (China, Japan and Rest of APAC)
5.5 Latin America
5.6 Middle East and Africa

Chapter 6 Company Profiles
6.1 Abbott Laboratories
6.2 Astrazeneca PLC
6.3 Biocryst Pharmaceuticals, Inc.
6.4 Chiron Corporation
6.5 CSL Limited
6.6 Daiichi Sankyo Co., Ltd.
6.7 Glaxosmithkline PLC
6.8 Mitsubishi Tanabe Pharma Corporation
6.9 Nanotherapeutics Inc.
6.10 Protein Sciences Corporation
6.11 Roche Holding AG
6.12 Sanofi SA
6.13 Shionogi & Co., Ltd.
6.14 Sinovac Biotech Ltd.

List Of Table :

TABLE 1 Market Positioning of Key Players in Global Influenza Therapeutics Market
TABLE 2 Global Influenza Therapeutics Market, by Therapy Type, 2015 – 2025 (US$ Mn)
TABLE 3 Global Influenza Therapeutics Market, by Geography, 2015 – 2025 (US$ Mn)
TABLE 4 North America Influenza Therapeutics Market, 2015 – 2025 (US$ Mn)
TABLE 5 Europe Influenza Therapeutics Market, 2015 – 2025 (US$ Mn)
TABLE 6 Asia Pacific Influenza Therapeutics Market, 2015 – 2025 (US$ Mn)
TABLE 7 Abbott Laboratories: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 8 Astrazeneca PLC: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 9 Biocryst Pharmaceuticals, Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 10 Chiron Corporation: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 11 CSL Limited: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 12 Daiichi Sankyo Co., Ltd.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 13 Glaxosmithkline PLC : Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 14 Mitsubishi Tanabe Pharma Corporation: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 15 Nanotherapeutics Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 16 Protein Sciences Corporation: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 17 Roche Holding AG: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 18 Sanofi SA: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 19 Shionogi & Co., Ltd.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 20 Sinovac Biotech Ltd.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)

List Of Figures :

FIG. 1 Influenza Therapeutics Market: Research Methodology
FIG. 2 Global Influenza Therapeutics Market, by Therapy Type, 2016 (US$ Mn)
FIG. 3 Global Influenza Therapeutics Market Share, by Geography, 2016 (Value %)
FIG. 4 Attractive Investment Proposition: Global Influenza Therapeutics Market, by Geography, 2016
FIG. 5 Global Vaccines Market for Influenza Therapeutics, 2015 – 2025 (US$ Mn)
FIG. 6 Global Drugs Market for Influenza Therapeutics, 2015 – 2025 (US$ Mn)
FIG. 7 Latin America Influenza Therapeutics Market, 2015 – 2025 (US$ Mn)
FIG. 8 Middle East and Africa Influenza Therapeutics Market, 2015 – 2025 (US$ Mn)

Based on therapy type, the global influenza therapeutics market is segmented as follows:  

  • Vaccines
    • Trivalent
    • Quadrivalent
  • Drugs
    • Zanamivir
    • Oseltamivir
    • Peramivir
    • Other

Influenza is an acute respiratory disease caused by influenza type A, B or C viruses infection, preventable by vaccination or chemoprophylaxis and is treatable by specific antiviral drugs. The  World Health Organization (WHO) reports that throughout the world, annual outbreaks result in 3–5 million severe cases and between 250,000- 500,000 deaths. Currently, influenza vaccines (also known as flu shots or jabs) dominating the global influenza market because government initiative for vaccination is prime factor that driving the growth of influenza vaccine market globally; The World Health Organization (WHO) and Centers for Disease Control and Prevention (CDC), European Centre for Disease Prevention and Control recommends yearly vaccination for nearly all people over the age of six months, especially those at high risk. CDC recommended oral oseltamivir (Tamiflu), inhaled zanamivir (Relenza), and intravenous peramivir (Rapivab) antiviral medications for the treatment; and trivalent- quadrivalent vaccines for the prevention of influenza, these all factors assisting growth of influenza market globally. 

Influenza Therapeutics Market

For the purpose of this study, the global influenza therapeutics market is categorized into:

  • North America
  • Europe
  • Asia Pacific
  • Latin America (LATAM)
  • Middle East and Africa (MEA)

Influenza Therapeutics Market

The World Health Organization (WHO) reports that throughout the world, annual outbreaks result in 3–5 million severe cases and between 250,000 and 500,000 deaths occurs due to influenza infection. It is observed that, currently North America followed by Europe dominating the global influenza market because government initiative such as Centers for Disease Control and Prevention (CDC), The European Centre for Disease Prevention and Control recommends yearly influenza vaccination for nearly all people over the age of six months, especially those at high risk are primarily driving the growth of influenza market in these region. Also some factors such as growing incidence of infectious diseases, higher healthcare awareness and increase in aging population are fueling the market growth in developed regions. On the other hand, Asia Pacific expected to grow at the highest CAGR during forecast period due to the higher number of targeted population, rising healthcare awareness and government initiatives in prevention of infectious disease would assist the market growth during forecast period in Asia Pacific region.

Choose License Type
Connect With Us
+1-800-361-8290
24/7 Research Support

Credence Webinars

Join Credence analysts to explore the latest IT Trends

view upcoming webinars

Our Clients